DS

Daowen Soon

Director Director DIN 08388621
DIN 08388621 First appointment Apr 2019 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since Apr 2019
Shareholding value •••• Premium profile

About Daowen Soon

Data last updated:

Daowen Soon was a Director at Astellas Pharma India Private Limited (2021–2024) and Director at Hoya Medical India Private Limited (2019–2020). The companies operate in Pharma and Healthcare.

DIN 08388621
Primary Designation Director
Industry Pharma
First Appointment 02 Apr 2019

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director10 May 20212008₹68.97 Cr (FY 2025)Active
Hoya Medical India Private Limited U51909DL2011FTC226966
Director02 Apr 20192011₹163 Cr (FY 2026)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Astellas Pharma India Private Limited
Hoya Medical India Private Limited
Premium access

Shareholding and investment profile for Daowen Soon

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Daowen Soon

Daowen Soon was first appointed on 02 Apr 2019 as Director at Hoya Medical India Private Limited. The most recent appointment on record is 10 May 2021 at Astellas Pharma India Private Limited.

Daowen Soon held 2 earlier board appointments: Astellas Pharma India Private Limited (Director, 10 May 2021 to 02 Feb 2024); Hoya Medical India Private Limited (Director, 02 Apr 2019 to 28 Aug 2020).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available